Transform Cancers
into Manageable Conditions
Transform Cancers
into Manageable Conditions
Load image
Background image
About Us
About Us
Company Overview
Adlai Nortye is a global clinical-stage biopharmaceutical company that is developing differentiated, innovative immuno-oncology medicines. Adlai Nortye focuses on discovering and developing important new treatments for cancer with a mission to improve patient lives by identifying and developing differentiated innovative medicines that help people live better, live longer. Through close collaborations with global partners, Adlai Nortye have successfully positioned itself in the field of immuno-oncology and h
Clinical Pipeline
Clinical Pipeline
R&D Platform
R&D Platform
Global talent mechanism
Global Talent
View More
Background image Background image
Competitive Pipeline
We have a promising and diverse pipeline consisting of preclinical, early, mid and late stage products, that focus on cancer treatment for unmet medical need and significant commercial opportunities. Through our active partnership programs and original discovery efforts, we are advancing a broad range of development targets with multiple opportunities for success in different types of cancer.
View More
Background image Background image
Background image Background image Development Platform Development Platform
Research and Development
Platform
Adlai Nortye is led by a world-class executive and core research and development team, more than 20 of whom have worked at top-tier global biopharmaceutical companies. With this breadth and depth of experience, our leadership team is well positioned to establish Adlai Nortye as a leading global presence in the immuno-oncology market.
View More
Media
View More